Could automating temperature excursion management hold the key to improving clinical supply processes?

There are a few key reasons why many sponsors are starting to ask whether current clinical supply processes are efficient enough.
Particularly when it comes to temperature excursion management, the current industry standard has several limitations.

Automating temperature excursion management

Digitalization and innovations in technology mean companies in every sector have more visibility and traceability of their processes than ever before. From HR to manufacturing, the automation of manual processes is not only saving time and money but allowing for seamless monitoring and enhanced business intelligence too.

But temperature excursion management is trailing behind. The issue of quarantined products due to short temperature intervals outside of allowed ranges is an important example of this.

The debate around new technologies

Despite most temperature excursions falling within pre-defined stability budgets, they trigger a quarantine while a time-consuming and inefficient manual review is conducted. This means that although the majority of quarantines do not result in wastage or replacement, QA and site staff are still required to complete a lengthy and time-consuming manual process of sharing data, compiling drug histories, calculations and reviews.

Automation, cloud and IoT technologies hold the key to making this crucial part of clinical supply processes more effective. It removes the need for these manual steps by providing seamless monitoring of every stage of the distribution journey.

Integrations are a must

Over 8,000 sites and 18,000 users are now automating the review process using the TSS Clinical Module, helping reduce quarantines by over 90% while eliminating the associated efforts and delays while ensuring that treatments are safe and available for patients.

By unlocking the potential of IoT, it becomes much simpler to upload temperature data from a range of devices through the clinical supply chain. Automation and seamless monitoring ensure there are no data gaps from manufacturing to dispensing, while any excursions and deviations are identified and communicated in seconds.

The TSS Clinical Module also offers 100% bi-directional integration with IRT systems, allowing for the automation of quarantine and release. By integrating with the eClinical infrastructure, this solution is not only automating manual processes but ensuring the safe delivery of treatments to patients.

Embracing change

Solutions that utilize the automation of temperature excursion management are no longer an unproven and potentially risky gamble for clinical sites. In fact, solutions like the TSS Clinical Module are already helping thousands of sites in over 60 countries to make their processes more efficient. Full traceability and visibility of the drug shipment process is no longer a pipedream. For a growing number of sites, it is the reality.

You may also be interested in

How live access to GxP data support supply chain best practices?

For companies in the pharmaceutical and life sciences industry, GxP data is a critical element of supply chain best practices. Indeed, there is hardly any requirement, from visibility to synchronized logistics, which does not rely on accessing the right data.
Read moreDownload Whitepaper

TSS Sponsors the 27th Annual Clinical Trial Supply Europe 2026 in Barcelona

TSS is proud to sponsor the 27th Annual Clinical Trial Supply Europe, taking place 24–25 February 2026 in Barcelona, Spain. The event brings together clinical supply professionals, sponsors, CROs, and solution providers to discuss how to strengthen resilience, quality, and patient safety across the clinical trial supply chain.
Read moreDownload Whitepaper
A person wearing blue gloves and a lab coat is handling a large metal plate, partially immersing it into an industrial liquid tank in a laboratory.

TSS Named a Di Gasell 2025

We’re proud to share that TSS has been recognized as a Di Gasell 2025, an award from the national financial newspaper Dagens industri celebrating Sweden’s fastest-growing and most successful companies.
Read moreDownload Whitepaper

You may also be interested in

What Do EMA’s Updated Shortage Prevention Guidelines Mean for Pharmaceutical Leaders?

The European Medicines Agency has updated its guidance and template for Shortage Prevention Plans. For pharmaceutical leaders, the development is more than a regulatory planning exercise. It is an invitation to examine whether their organizations can identify supply vulnerabilities early and respond before an issue affects medicine availability.
Read more

Extending TempMonitor BLE to Ultra-Low Temperatures

Introducing the new TSS Dry Ice Probes, enginereed for accurate and GxP-compliant temperature monitoring down to –90°C. Available in two lengths for flexible setup — built to safeguard product integrity in every environment.
Read more

Subscribe to our newsletter

Sign up for our newsletter to receive all the latest TSS news and insights in temperature management solutions.